Ken Griffin View Ray, Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$0.35 - $3.28 $1,295 - $12,136	3,700 Added 17.21%	25,200 $8,000
Q1 2023 May 15, 2023	SELL	$3.28 - $4.81 $328 - $480	-100 Reduced 0.46%	21,500 $74,000
Q4 2022 Feb 14, 2023	BUY	$3.65 - $4.82 $6,570 - $8,676	1,800 Added 9.09%	21,600 $96,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $25,536 - $38,112	-9,600 Reduced 32.65%	19,800 $72,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.